TTD | Drug: D00SLJ

Drug General Information
Drug ID	D00SLJ
Former ID	DNC013213
Drug Name	N1-(3,3-diphenylpropyl)-N3-hydroxymalonamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528703]
Structure		Download 2D MOL 3D MOL
Formula	C18H20N2O3
Canonical SMILES	C1=CC=C(C=C1)C(CCNC(=O)CC(=O)NO)C2=CC=CC=C2
InChI	1S/C18H20N2O3/c21-17(13-18(22)20-23)19-12-11-16(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-10,16,23H,11-13H2,(H,19,21)(H,20,22)
InChIKey	UYRUQIFSLBHLGY-UHFFFAOYSA-N
PubChem Compound ID	44420656
Target and Pathway
Target(s)	Aminopeptidase N	Target Info	Inhibitor	[528703]
BioCyc Pathway	Glutathione-mediated detoxification
KEGG Pathway	Glutathione metabolism
	Metabolic pathways
	Renin-angiotensin system
	Hematopoietic cell lineage
Pathway Interaction Database	C-MYB transcription factor network
PathWhiz Pathway	Glutathione Metabolism
Reactome	Metabolism of Angiotensinogen to Angiotensins
WikiPathways	Metabolism of Angiotensinogen to Angiotensins
	Cardiac Progenitor Differentiation
	miR-targeted genes in squamous cell - TarBase
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	miR-targeted genes in leukocytes - TarBase
	Glutathione metabolism
References
Ref 528703	J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
Ref 528703	J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information